Proactive Drug Monitoring Is Associated With Higher Persistence to Infliximab and Adalimumab Treatment and Lower Healthcare Utilization Compared With Reactive and Clinical Monitoring
Syed, Nauroz, Tolaymat, Mazen, Brown, Sara A, Sivasailam, Barathi, Cross, Raymond KVolume:
2
Journal:
Crohn's & Colitis 360
DOI:
10.1093/crocol/otaa050
Date:
July, 2020
File:
PDF, 179 KB
2020